SCYNEXIS
SCYX
$2.42
Share price
2.77%
Change (1 day)
-7.82%
Change (1 year)
Categories
P/S ratio for SCYNEXIS (SCYX)
P/S ratio as of June 2024 (TTM): 0.6324
According to SCYNEXIS's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.632422. At the end of 2023 the company had a P/S ratio of 0.5921.
P/S ratio history for SCYNEXIS from 2014 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 0.5921 | -94.08% |
| 2022 | 10.0 | -9.84% |
| 2021 | 11.1 | |
| 2020 | N/A | -100% |
| 2019 | 733 | 711.62% |
| 2018 | 90.3 | -65.12% |
| 2017 | 259 | -13.42% |
| 2016 | 299 | -11.03% |
| 2015 | 336 | 3905.94% |
| 2014 | 8.39 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Galmed Pharmaceuticals
GLMD | N/A | N/A | 🇮🇱 Israel |
 Catalyst Pharmaceuticals CPRX | 4.63 | 631.45% | 🇺🇸 USA |
 Catalent CTLT | 2.35 | 271.02% | 🇺🇸 USA |
 KemPharm KMPH | 19.2 | 2,931.11% | 🇺🇸 USA |